Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2005 3
2006 2
2009 4
2010 1
2011 1
2015 1
2016 3
2020 2
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
2-(6-Bromo-3-pyrid-yl)-8-methyl-imidazo[1,2-a]pyrazine.
Huang B, Rui E, Wythes M, Kung PP, Moore C, Rheingold AL, Yanovsky A. Huang B, et al. Among authors: rui e. Acta Crystallogr Sect E Struct Rep Online. 2010 Jun 23;66(Pt 7):o1723. doi: 10.1107/S1600536810022993. Acta Crystallogr Sect E Struct Rep Online. 2010. PMID: 21587940 Free PMC article.
6-Methyl-sulfanyl-4H-pyrimido[1,6-a]pyrimidin-4-one.
Huang Q, Richardson PF, Rui E, Rheingold AL, Yanovsky A. Huang Q, et al. Among authors: rui e. Acta Crystallogr Sect E Struct Rep Online. 2009 Sep 30;65(Pt 10):o2572. doi: 10.1107/S1600536809038562. Acta Crystallogr Sect E Struct Rep Online. 2009. PMID: 21578009 Free PMC article.
SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance.
Jensen-Pergakes K, Tatlock J, Maegley KA, McAlpine IJ, McTigue M, Xie T, Dillon CP, Wang Y, Yamazaki S, Spiegel N, Shi M, Nemeth A, Miller N, Hendrickson E, Lam H, Sherrill J, Chung CY, McMillan EA, Bryant SK, Palde P, Braganza J, Brooun A, Deng YL, Goshtasbi V, Kephart SE, Kumpf RA, Liu W, Patman RL, Rui E, Scales S, Tran-Dube M, Wang F, Wythes M, Paul TA. Jensen-Pergakes K, et al. Among authors: rui e. Mol Cancer Ther. 2022 Jan;21(1):3-15. doi: 10.1158/1535-7163.MCT-21-0620. Epub 2021 Nov 4. Mol Cancer Ther. 2022. PMID: 34737197
Plasmodium vivax spleen-dependent genes encode antigens associated with cytoadhesion and clinical protection.
Fernandez-Becerra C, Bernabeu M, Castellanos A, Correa BR, Obadia T, Ramirez M, Rui E, Hentzschel F, López-Montañés M, Ayllon-Hermida A, Martin-Jaular L, Elizalde-Torrent A, Siba P, Vêncio RZ, Arevalo-Herrera M, Herrera S, Alonso PL, Mueller I, Del Portillo HA. Fernandez-Becerra C, et al. Among authors: rui e. Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):13056-13065. doi: 10.1073/pnas.1920596117. Epub 2020 May 21. Proc Natl Acad Sci U S A. 2020. PMID: 32439708 Free PMC article.
Characterization of the CHK1 allosteric inhibitor binding site.
Vanderpool D, Johnson TO, Ping C, Bergqvist S, Alton G, Phonephaly S, Rui E, Luo C, Deng YL, Grant S, Quenzer T, Margosiak S, Register J, Brown E, Ermolieff J. Vanderpool D, et al. Among authors: rui e. Biochemistry. 2009 Oct 20;48(41):9823-30. doi: 10.1021/bi900258v. Biochemistry. 2009. PMID: 19743875
Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors.
Kung PP, Rui E, Bergqvist S, Bingham P, Braganza J, Collins M, Cui M, Diehl W, Dinh D, Fan C, Fantin VR, Gukasyan HJ, Hu W, Huang B, Kephart S, Krivacic C, Kumpf RA, Li G, Maegley KA, McAlpine I, Nguyen L, Ninkovic S, Ornelas M, Ryskin M, Scales S, Sutton S, Tatlock J, Verhelle D, Wang F, Wells P, Wythes M, Yamazaki S, Yip B, Yu X, Zehnder L, Zhang WG, Rollins RA, Edwards M. Kung PP, et al. Among authors: rui e. J Med Chem. 2016 Sep 22;59(18):8306-25. doi: 10.1021/acs.jmedchem.6b00515. Epub 2016 Sep 6. J Med Chem. 2016. PMID: 27512831
18 results